School of Medicine, University of Dundee, Dundee, UK.
Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Commun Biol. 2020 Jul 31;3(1):411. doi: 10.1038/s42003-020-01145-3.
Although palmitoylation regulates numerous cellular processes, as yet efforts to manipulate this post-translational modification for therapeutic gain have proved unsuccessful. The Na-pump accessory sub-unit phospholemman (PLM) is palmitoylated by zDHHC5. Here, we show that PLM palmitoylation is facilitated by recruitment of the Na-pump α sub-unit to a specific site on zDHHC5 that contains a juxtamembrane amphipathic helix. Site-specific palmitoylation and GlcNAcylation of this helix increased binding between the Na-pump and zDHHC5, promoting PLM palmitoylation. In contrast, disruption of the zDHHC5-Na-pump interaction with a cell penetrating peptide reduced PLM palmitoylation. Our results suggest that by manipulating the recruitment of specific substrates to particular zDHHC-palmitoyl acyl transferases, the palmitoylation status of individual proteins can be selectively altered, thus opening the door to the development of molecular modulators of protein palmitoylation for the treatment of disease.
尽管棕榈酰化调节着许多细胞过程,但迄今为止,操纵这种翻译后修饰以获得治疗益处的努力都没有成功。Na+-泵辅助亚基磷酸丙糖异构酶 1(PLM)可被 zDHHC5 棕榈酰化。在这里,我们发现 Na+-泵的α亚基被募集到 zDHHC5 上的一个特定位点,该位点包含一个紧邻膜的两亲性螺旋,从而促进了 PLM 的棕榈酰化。该螺旋的特异性棕榈酰化和 GlcNAc 化增加了 Na+-泵与 zDHHC5 之间的结合,从而促进了 PLM 的棕榈酰化。相比之下,用穿透细胞膜的肽破坏 zDHHC5-Na+-泵的相互作用会减少 PLM 的棕榈酰化。我们的结果表明,通过操纵特定底物向特定 zDHHC 棕榈酰转移酶的募集,可以选择性地改变单个蛋白质的棕榈酰化状态,从而为治疗疾病的蛋白质棕榈酰化的分子调节剂的开发开辟了道路。